Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02677922
Title	A Safety and Efficacy Study of Oral AG-120 Plus Subcutaneous Azacitidine and Oral AG-221 Plus Subcutaneous Azacitidine in Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML)
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Celgene
Indications	acute myeloid leukemia myeloproliferative neoplasm myelodysplastic syndrome
Therapies	Azacitidine + Ivosidenib Azacitidine Azacitidine + Enasidenib
Age Groups:	senior \| adult
Covered Countries	USA \| ITA \| FRA \| ESP \| DEU \| CAN